Sumitomo Pharma Co., Ltd.: Asthma trials

The registry lists 16 Asthma studies with Sumitomo Pharma Co., Ltd. as lead sponsor. 0 are open to participants now and 3 have results posted.

Phase 2 6Phase 3 9Phase 4 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric SubjectsTerminatedNCT02150499Phase 3Results posted
• A Safety, Efficacy and Tolerability Study in Pediatric Subjects With AsthmaCompletedNCT00809757Phase 3Results posted
• A Safety and Tolerability Study of Arformoterol Tartrate Inhalation Solution in Pediatric SubjectsCompletedNCT00583947Phase 2Results posted
• A Study of Daily Dosing With Levalbuterol, Racemic Albuterol, and Placebo in Pediatric Subjects With AsthmaCompletedNCT01656811Phase 2
• Dose Response Study of Levalbuterol in the Prevention of Exercise Induced Bronchoconstriction Compared to Racemic AlbuterolCompletedNCT00685425Phase 3
• Dose Response Study of Levalbuterol in the Prevention of Exercise Induced Bronchoconstriction Compared to Racemic Albuterol in Pediatric SubjectsCompletedNCT00685347Phase 2
• Safety and Tolerability Study of Levalbuterol HFA Compared to Racemic Albuterol HFA in Subjects With AsthmaCompletedNCT00685022Phase 2
• Safety and Tolerability Study of Levalbuterol HFA and Racemic Albuterol HFA in Pediatrics Subjects With AsthmaCompletedNCT00684866Phase 2
• A Safety and Tolerability Study of Levalbuterol HFA Metered Dose Inhaler in Subjects With AsthmaCompletedNCT00684827Phase 2
• Costs & Outcomes of Hospitalization/Treatment With Levalbuterol & Albuterol in Asthma or Chronic Obstructive Pulmonary Disease (COPD) SubjectsCompletedNCT00667797Phase 4
• Efficacy and Safety of Levalbuterol Versus Racemic Albuterol in AsthmaCompletedNCT00667407Phase 3
• Reliability of a Top Mount Actuation Indicator With Levalbuterol MDI in Adult and Pediatric Subjects With Asthma or COPDCompletedNCT00583986Phase 3
• Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With AsthmaCompletedNCT00073840Phase 3
• Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With AsthmaCompletedNCT00073827Phase 3
• Study of Daily Dosing With Levalbuterol, Racemic Albuterol, and Placebo in Pediatric Subjects With AsthmaCompletedNCT00073814Phase 3
• Long Term Safety Study of Levalbuterol and Racemic Albuterol in Subjects Twelve Years of Age and Older With AsthmaCompletedNCT00064389Phase 3